These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8137040)

  • 1. How to monitor the dosage of warfarin.
    Bussey HI
    Heart Dis Stroke; 1993; 2(5):388-92. PubMed ID: 8137040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
    Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
    Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home prothrombin time monitoring: a literature analysis.
    Yang DT; Robetorye RS; Rodgers GM
    Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral anticoagulation treatment--control, risks, benefits, and informed consent].
    Froom P; Hermoni D; Barak M
    Harefuah; 2003 Jan; 142(1):56-60, 77. PubMed ID: 12647491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
    Sanfelippo MJ; Sennet J; McMahon EJ
    WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of concurrent use of warfarin with potentially interacting drugs.
    Wittkowsky AK; Boccuzzi SJ; Wogen J; Wygant G; Patel P; Hauch O
    Pharmacotherapy; 2004 Dec; 24(12):1668-74. PubMed ID: 15585436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
    Anderson DR; Harrison L; Hirsh J
    Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation.
    Bianco TM; Bussey HI; Farnett LE; Linn WD; Roush MK; Wong YW
    Pharmacotherapy; 1992; 12(6):435-9. PubMed ID: 1492006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.
    Ellis RF; Stephens MA; Sharp GB
    Am J Hosp Pharm; 1992 Feb; 49(2):387-94. PubMed ID: 1554003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of a possible interaction between warfarin and levofloxacin.
    McCall KL; Scott JC; Anderson HG
    Pharmacotherapy; 2005 Jan; 25(1):67-73. PubMed ID: 15767222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral corticosteroids on chronic warfarin therapy.
    Hazlewood KA; Fugate SE; Harrison DL
    Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.
    Oberg KC
    Pharmacotherapy; 1998; 18(2):386-91. PubMed ID: 9545160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of influenza vaccine in patients receiving long-term warfarin therapy.
    Weibert RT; Lorentz SM; Norcross WA; Klauber MR; Jagger PI
    Clin Pharm; 1986 Jun; 5(6):499-503. PubMed ID: 3720216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation.
    Khan TI; Kamali F; Kesteven P; Avery P; Wynne H
    Br J Haematol; 2004 Aug; 126(4):557-64. PubMed ID: 15287950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
    Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
    Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.